AstraZeneca sees 2022 growth as dividend rises but COVID boo

AstraZeneca sees 2022 growth as dividend rises but COVID boost falls

Related Keywords

Sweden , Swedish , Pascal Soriot , Astrazeneca , Executive Pascal Soriot , Igher 2022 Sales , Dividend Raise , Better Than Expected , Fourth Quarter Profit , Covid 19 Antibody Treatment , Cancer Drugs ,